SCHEMBL21775715

SCHEMBL21775715

CN(C)c1ccc(OCc2ccccc2)c(C(=O)OCCl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.51
ALDH1A1 P00352 2/20 0.50
MAPT P10636 2/20 0.50
HPGD P15428 1/20 0.50
HTT P42858 1/20 0.50
FOLH1 Q04609 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
NOX1 Q9Y5S8 1/20 0.44
KDM4E B2RXH2 1/20 0.44
POLB P06746 1/20 0.44
PTGER1 P34995 1/20 0.44
PTPN2 P17706 2/20 0.43
PTPN1 P18031 2/20 0.43
PTPN6 P29350 2/20 0.43
APP P05067 2/20 0.43
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21774384 0.86 LRRK2 (0.56) LRRK2ALDH1A1MAPTHPGDFOLH1
SCHEMBL21775803 0.84 FOLH1 (0.62) LRRK2ALDH1A1MAPTHPGDFOLH1
SCHEMBL21775718 0.79 KDM5A (0.45) LRRK2ALDH1A1MAPTHPGDHTT
SCHEMBL9865782 0.75 ALDH1A1 (0.42) LRRK2ALDH1A1MAPTHPGDHTT
SCHEMBL21775714 0.74 HTT (0.45) ALDH1A1MAPTHPGDHTTSMN1; SMN2
SCHEMBL1646770 0.74 LRRK2 (0.56) LRRK2ALDH1A1MAPTHTTFOLH1
SCHEMBL1649274 0.74 PTGER1 (0.62) LRRK2ALDH1A1HTTFOLH1KMT2A
SCHEMBL23809724 0.72 ALDH1A1 (0.62) ALDH1A1HTTFOLH1SMN1; SMN2MEN1
SCHEMBL4415350 0.72 HTT (0.75) ALDH1A1HTTSMN1; SMN2MEN1KMT2A
SCHEMBL1647432 0.72 TDP1 (0.58) ALDH1A1MAPTHPGDHTTFOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11692004-B2 Substituted pyrazole compound, preparation method therefor, pharmaceutical composition and medical use thereof JIANGSU VANGUARD PHARMACEUTICAL CO., LTD. (CN) 2023-07-04 US disclosed
US-11692004-B2 Substituted pyrazole compound, preparation method therefor, pharmaceutical composition and medical use thereof JIANGSU VANGUARD PHARMACEUTICAL CO., LTD. (CN) 2023-07-04 US disclosed
WO-2020038279-A1 SUBSTITUTED PYRAZOLE COMPOUND, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USE THEREOF 天津谷堆生物医药科技有限公司 2020-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11692004-B2 Substituted pyrazole compound, preparation method therefor, pharmaceutical composition and medical use thereof FARS2, GOT2, HADHB LRRK2 615/4885ALDH1A1 2197/4885MAPT 856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.